Top of page
Lawyers

Michael Mollerus

Lawyers

Filters

Anacor $5.2 billion acquisition by Pfizer

Davis Polk is advising Anacor Pharmaceuticals, Inc. on its approximately $5.2 billion acquisition by Pfizer Inc. The closing of the transaction, which is expected in the third quarter…

Medallion Financial Corp. $30 Million Notes Offering

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Medallion Financial Corp. of $30 million aggregate principal amount of 9.000% notes due…

Davis Polk Advises Markit on Its Merger with IHS

Davis Polk is advising Markit on its all-share merger of equals with IHS valued at more than $13 billion. The transaction is expected to close in the second half of 2016, subject to…

KKR & Co. L.P. $345 Million Preferred Units Offering

Davis Polk advised the joint book-running managers on an SEC-registered offering by KKR & Co. L.P. of 13,800,000 6.75% Series A preferred units, which includes the full exercise of the…

IBM €2.25 Billion Notes Offering

Davis Polk advised the underwriters in connection with a public offering by International Business Machines Corporation of €1 billion principal amount of its 0.500% notes due 2021, €750…

Honeywell International €4 Billion Notes Offering

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Honeywell International Inc. of €1 billion aggregate principal amount of its floating…
Back to top